Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patterns of Inclisiran Use in the Real World: A Retrospective Analysis of US Databases

NCT07023445 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT07023445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07023445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patterns of Inclisiran Use in the Real World: A Retrospective Analysis of US Databases
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
January 20, 2023
Completion date
June 28, 2024
Enrollment
37,688 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease, familial hypercholesterolemia